Karmanos Cancer Institute, first cancer center in Michigan to offer CAR-T Therapy for an aggressive type of non … – GlobeNewswire (press release)
GlobeNewswire (press release) |
Karmanos Cancer Institute, first cancer center in Michigan to offer CAR–T Therapy for an aggressive type of non …
GlobeNewswire (press release) The Karmanos Cancer Institute in Detroit is the first center in Michigan approved to treat adult patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL) with the commercially approved chimeric antigen receptor (CAR) T-cell therapy. CAR-T … |
